A Study Of Exercise In Patients With Spontaneous Coronary Artery Dissection And Fibromuscular Dysplasia

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Apr 30, 2027 → Aug 30, 2027
See other at-risk trials from Mayo Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date changed from estimate of Sep 11, 2026 to Sep 1, 2026
    • Eligibility criteria expanded, about 6 words
  2. Start date: Aug 1, 2026 to Sep 11, 2026
    • Primary completion pushed from Apr 30, 2027 to Aug 30, 2027
    • Study completion pushed from Jul 1, 2027 to Nov 1, 2027
    v3
  3. Start date: Apr 1, 2026 to Aug 1, 2026v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,027 trials monitored
See 130 trials at risk
The purpose of this study is to assess the cardiopulmonary, hemodynamic, and symptom responses to acute bouts of varying intensity aerobic and resistance exercise in people with Spontaneous Coronary Artery Dissection (SCAD) and/or Fibromuscular Dysplasia (FMD).
Trial Details
NCT Number NCT07526766
Lead Sponsor Mayo Clinic
Conditions
(from sponsor)		 Fibromuscular Dysplasia, Spontaneous Coronary Artery Dissection
Related terms Coronary Artery Dissection, Spontaneous, Fibromuscular Dysplasia
Enrollment 28 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov